Screening for gastric cancer in Asia: current evidence and practice.

By W. Leung, Ming-Shiang Wu, Y. Kakugawa, Jae J Kim, K. Yeoh, K. Goh, Kaichun Wu, Deng-Chyang Wu, J. Sollano, U. Kachintorn and 5 more. The Lancet Oncology, 2008

802 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/ba2701fe1ca41d453194f07dd6b8cb9c8781021a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Robert Sitarz
2. M. Malvezzi
3. A. Ferro
4. Małgorzata Skierucha
5. P. Bertuccio
6. R. Maciejewski
7. P. Karimi
8. F. Levi

Citations in the corpus

• The gastric precancerous cascade (2012, background): “Both systems ignore the type of IM as a risk factor, although a later study reported a strong association between incomplete IM and the high-risk OLGA stages [78].”
• Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention (2014, background): “Although the value of screening mass populations for gastric cancer remains controversial (141), it has been”
• Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. (2014, background): “* – Stages of cigarette epidemic for in the United States [62], – Dissemination of food refrigeration in pylori infection [27,32,33], / – [66], W – [66], ( – [67], N – [68], R – [69],”
• Gastric cancer: epidemiology, prevention, classification, and treatment (2018, background): “%) than in an intact stomach.39 Aspirin and NSAID users are shown to be at a reduced risk of GC.40 On the other hand, the side effects of these are bleeding, perforation, or gastric outlet obstruction,41 and therefore, these drugs are not recommended for patients with Powered by TCPDF (www.tcpdf.org”